UnitedHealth Group Files Q3 2024 10-Q

TL;DR

**UNH Q3 10-Q FILED: Financials and segment performance detailed for the period ending Sept 30, 2024.**

AI Summary

UnitedHealth Group Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers financial performance and operational details for the third quarter and the year-to-date period. Key financial figures and segment performance are detailed within the report, providing insights into the company's ongoing business activities and financial health.

Why It Matters

This filing provides crucial financial data for investors and analysts to assess UnitedHealth Group's performance and outlook in the healthcare sector.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.

Key Players & Entities

• UNITEDHEALTH GROUP INC (company) — Filer of the 10-Q
• 0000731766 (company) — Central Index Key for UnitedHealth Group Inc.
• 20240930 (date) — Conformed period of report
• 20241104 (date) — Filing date

FAQ

Filing Documents

• unh-20240930.htm (10-Q) — 1636KB
• ex311unh2024930.htm (EX-31.1) — 19KB
• ex321unh2024930.htm (EX-32.1) — 9KB
• unh-20240930_g1.jpg (GRAPHIC) — 16KB
• 0000731766-24-000323.txt ( ) — 8145KB
• unh-20240930.xsd (EX-101.SCH) — 36KB
• unh-20240930_cal.xml (EX-101.CAL) — 86KB
• unh-20240930_def.xml (EX-101.DEF) — 250KB
• unh-20240930_lab.xml (EX-101.LAB) — 579KB
• unh-20240930_pre.xml (EX-101.PRE) — 405KB
• unh-20240930_htm.xml (XML) — 1447KB

Financial Information

Part I. Financial Information Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited) 1 Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023 1 Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2024 and 2023 2 Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2024 and 2023 3 Condensed Consolidated Statements of Changes in Equity for the Three and Nine Months Ended September 30, 2024 and 2023 4 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2024 and 2023 6 Notes to the Condensed Consolidated Financial Statements 7 1. Basis of Presentation 7 2. Investments 8 3. Fair Value 10 4. Medical Costs Payable 11 5. Short-Term Borrowings and Long-Term Debt 12 6. Other Intangible Assets 12 7. Shareholder's Equity 13 8. Commitments and Contingencies 13 9. Dispositions and Held for Sale 14 10. Segment Financial Information 15 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 26 Item 4.

Controls and Procedures

Controls and Procedures 26

Other Information

Part II. Other Information Item 1.

Legal Proceedings

Legal Proceedings 26 Item 1A.

Risk Factors

Risk Factors 26 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 27 Item 5. Other Information 27 Item 6. Exhibits 28

Signatures

Signatures 29 PART I

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS UnitedHealth Group Condensed Consolidated Balance Sheets (Unaudited) (in millions, except per share data) September 30, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents $ 32,400 $ 25,427 Short-term investments 4,734 4,201 Accounts receivable, net 20,024 21,276 Other current receivables, net 27,461 17,694 Assets under management — 3,755 Prepaid expenses and other current assets 7,639 6,084 Total current assets 92,258 78,437 Long-term investments 48,689 47,609 Property, equipment and capitalized software, net 10,139 11,450 Goodwill 105,978 103,732 Other intangible assets, net 23,594 15,194 Other assets 18,651 17,298 Total assets $ 299,309 $ 273,720 Liabilities, redeemable noncontrolling interests and equity Current liabilities: Medical costs payable $ 33,951 $ 32,395 Accounts payable and accrued liabilities 33,080 31,958 Short-term borrowings and current maturities of long-term debt 3,909 4,274 Unearned revenues 3,320 3,355 Other current liabilities 27,305 27,072 Total current liabilities 101,565 99,054 Long-term debt, less current maturities 74,101 58,263 Deferred income taxes 4,014 3,021 Other liabilities 15,174 14,463 Total liabilities 194,854 174,801 Commitments and contingencies (Note 8) Redeemable noncontrolling interests 4,574 4,498 Equity: Preferred stock, $ 0.001 par value - 10 shares authorized; no shares issued or outstanding — — Common stock, $ 0.01 par value - 3,000 shares authorized; 923 and 924 issued and outstanding 9 9 Additional paid-in capital 461 — Retained earnings 96,518 95,774 Accumulated other comprehensive loss ( 2,453 ) ( 7,027 ) Nonredeemable noncontrolling interests 5,346 5,665 Total equity 99,881 94,421 Total liabilities, redeemable noncontrolling interests and equity $ 299,309 $ 273,720 See Notes to the Condensed Consolidated Financial Statements 1 Table of Contents UnitedHealth Group Condensed Consolidated Statements of Operations

View Full Filing

View this 10-Q filing on SEC EDGAR